MPhA News

Small Doses

March 20

As a reminder, the MPhA website is not optimized for Internet Explorer. We recommend the use of Chrome or Firefox.

News from MPhA

COVID-19 Update

MPhA has created a landing page on our website for updates and resources on COVID-19. Should you have any questions or suggestions on resources that we can add to our website, please email COVID19@mpha.org. MPhA is also planning to set up a couple times for members to join a webinar so we can discuss what others are doing and all assist each other during this time. Visit the page at https://www.mpha.org/page/covid-19


Mission Moments

COP Ranks Third among U.S. Pharmacy Schools

U.S. News & World Report has named the University of Minnesota College of Pharmacy (COP) as the third best in the nation. COP Dean Lynda Welage said in a statement, “Throughout the history of the U.S. News & World Report rankings for colleges of pharmacy, the University of Minnesota College of Pharmacy has always remained among the top schools in the country. We know this is because of the unique program we offer, the tremendous work and dedication of our faculty, staff and students, as well as the exceptional support we receive from friends and alumni of the college.”

Dean Welage continued, “This moment of crisis in our national health care environment exemplifies the need for us to continue striving to fulfill our mission. We are preparing students to be innovative problem solvers who tackle big health care challenges like this one and the many that are sure to come.” Read the full report on U.S. pharmacy schools: https://www.usnews.com/best-graduate-schools/top-health-schools/pharmacy-rankings

COP Faculty Receive Award from AACP

Claire Kolar, PharmD, PhD, and MPhA member Kristin K. Janke, PhD, have been announced as winners of the American Association of Colleges of Pharmacy (AACP) Rufus A. Lyman Award for their paper, “Aiding Transformation from Student to Practitioner by Defining Threshold Concepts for the Pharmacists’ Patient Care Process.”

Gayle A Brazeau, PhD, editor of AJPE, wrote, “This manuscript makes a significant contribution to pharmacy education because of its timeliness, originality and significant impact to the education of our students and the practice of pharmacy as colleges/schools work in the transition of our students to become practitioners through the use of the Pharmacists’ Patient Care Process (PPCP).”

This award and others will be presented at Pharmacy Education 2020, scheduled for July 18-22 in Long Beach, Calif.

University of Minnesota Launches Clinical Trial to Prevent COVID-19

Are you a health care worker or know a health care worker who was exposed to COVID-19? Or, are you a health care worker sharing a home with someone who has COVID-19? The University of Minnesota has launched a clinical trial studying a drug that may help prevent infection in those exposed to coronavirus. This study is currently open to ALL health care workers across the U.S. Email us at covid19@umn.edu to enroll.#IDTwitter Please share with your networks.

Pharmacy Students among Those Volunteering for MN Covidsitters

Students from the University of Minnesota College of Pharmacy are among those participating in MN Covidsitters — a volunteer group of students who are helping with child care and errands for those working the front lines in health care and public health. Students from medicine, nursing, pharmacy, dental, public health, veterinary medicine and education are encouraged to participate: https://www.mncovidsitters.org/forstudents

MPhA Needs Your Help

How Is COVID-19 Affecting Your Practice?

MPhA wants to hear from our members! How has your company and/or your practice been affected by COVID-19? Email your thoughts to COVID19@mpha.org. One example: on March 18, Sterling Pharmacy announced that the company is moving to closed-door facilities. All the company’s pharmacies will remain open and will continue to fill prescriptions, but patients will need to receive their orders via curbside pickup, free home delivery or free mail delivery. Sterling management believes this will help to protect the health and safety of its employees.

APMS

Minnesota News

Board of Pharmacy Provides FAQs on COVID-19

The Minnesota Board of Pharmacy (BOP) has sent pharmacists an FAQ document to address many of the questions received by the Board related to COVID-19, among them: Can a pharmacy completely close its doors? What are the BOP’s recommendations for pharmacies that choose to stay open? Must home delivery employees get a signature from patients? Download the March 16 document http://bit.ly/BOP-FAQs0316. The BOP encourages pharmacists to check its website https://mn.gov/boards/pharmacy/ frequently for updates.

Legislators Approve $200 Million in Emergency Funding for COVID-19

From WCCO-TV, March 17: Minnesota lawmakers passed emergency legislation on March 17 that would provide $200 million for investment in the health care system as the state mounts a defense against the novel coronavirus (COVID-19).

The bill allocates $150 million for a new health care response fund. The Minnesota Department of Health will use it to make grants to providers to help them respond to the outbreak. The money can be used for temporary sites to provide testing services, treatment beds and isolate affected patients, among other things.

Read the full report
http://bit.ly/COVID-19-Funding

Hospitals Plan for Stages of COVID-19 Patients

From Minnesota Public Radio, March 17: The state's hospital systems are preparing for what they know will be a difficult test from the novel coronavirus. Hospital leaders say they anticipate a lot of need, but are worried about a surge in COVID-19 patients that could tax the equipment they need to do their jobs safely.

While hospitals have been preparing over the last two months, the key is for people to stay home when they are sick, stay at least 6 feet away from others and, as much as possible, try to cut down daily interactions outside of their homes, said Rahul Koranne, MD, president and CEO of the Minnesota Hospital Association.

Read/listen to the full report.
http://bit.ly/MPR-Hospital-Surge

MHealth Fairview Offers Coronavirus Screening

On March 15, MHealth Fairview announced that it will offer online screening for people who think they may have been exposed to COVID-19. People do not need to be patients of the MHealth Fairview system to get a screening, and there is no co-pay for the patient. Learn more. https://www.mhealth.org/Care/Conditions/COVID-19
Related: MDH Updates Guidance on Testing Criteria

http://bit.ly/MDH-COVID19Guidance

Grocery Stores Alter Hours, Reserve Special Shopping Times for Those at Risk

From KMSP-TV, March 17: The Minnesota Grocers Association is asking customers to be calm, respectful, flexible and patient as they head to grocery stores during the COVID-19 outbreak. Most grocers are open for business, but many have cut back on the hours when stores are open. Many have also reserved the first hour of service for the elderly, immunocompromised, health care staff and first responders. Read the full story: http://bit.ly/MN-Grocers-COVID19

National News

APhA Urges Insurers, PBMs to Remove Barriers on Prescription Refills

From APhA website, March 13: The American Pharmacists Association (APhA) is calling on all of the nation’s health insurers and pharmaceutical benefit managers (PBMs) to immediately remove/waive any administrative barriers on pharmacists and patients for access to early medication refills from their pharmacy of choice to ensure patients have the medications necessary for chronic diseases to address their needs during the ongoing coronavirus pandemic.

Without immediate changes to implement broad, system-wide authorization for early or emergency refills for chronic medications, patients may have to endure long waits at the pharmacy while the pharmacist addresses the administrative barriers. Not only does this frustrate patients, but it challenges pharmacists’ ability to deliver patient care services.

Read the full statement. http://bit.ly/APhA-RxRefills

Related: APhA Launches Page for Pharmacists on COVID-19 https://www.pharmacist.com/CEOBlog/tough-choices-strong-actions

Related: Pharmacy Times Offers Tips for Pharmacies and Pharmacists http://bit.ly/PharmacyTimesCovidTips

Related: APhA Statement on Protecting the Health of Pharmacy Providers http://bit.ly/APhA-ProtectPharmHealth

Pharmacy Groups Request Clarification from FDA on Compounding

The American Pharmacists Association (APhA), Alliance for Pharmacy Compounding (APC), National Community Pharmacists Association (NCPA) and the National Alliance for State Pharmacy Associations (NASPA) have issued a joint letter to the U.S. Food & Drug Administration (FDA) seeking clarity on the FDA’s recent decision to allow compounding pharmacists to produce hand sanitizer during the COVID-19 health emergency.

Among the questions and concerns posed by the pharmacy groups: How will shipping of hand sanitizers produced by compounding pharmacies be addressed? Many state boards of pharmacy are awaiting guidelines from FDA before allowing these products to be made available. Pharmacies have indicated difficulty in locating sufficient supplies of 75% isopropyl alcohol and seek help from FDA.

Read the full letter. http://bit.ly/FDA-Compounding0318

NIH Clinical Trial of Investigational Vaccine for COVID-19 Begins

A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle.

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is funding the trial. KPWHRI is part of NIAID’s Infectious Diseases Clinical Research Consortium. The open-label trial will enroll 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks. The first participant received the investigational vaccine on March 16.

Read the full news release. http://bit.ly/KPWHRI-Vaccine

Related: FDA Issues Guidance on Clinical Trials http://bit.ly/FDA-ClinicalTrial

DEA National Prescription Drug Take Back Day: April 25

The National Prescription Drug Take Back Day addresses a crucial public safety and public health issue. According to the 2018 National Survey on Drug Use and Health, 9.9 million Americans misused controlled prescription drugs. The study shows that a majority of abused prescription drugs were obtained from family and friends, often from the home medicine cabinet. The next National Prescription Drug Take Back Day is scheduled for Saturday, April 25, at 10 a.m. Information about collection sites will be available soon, along with public service announcements to educate the public. Visit the DEA Take Back site for more information.

MPhA Events

Register Now! MPhA Virtual Town Hall: Long-Acting Injectables

Tuesday, April 7 • 6-7:30 p.m. • Presenters: Amie Jo Digatono, PharmD, BCPP, and Julie Jackman, PharmD, BC-ACP

A review of the FDA-approved indications and the use of long-acting injectable (LAI) antipsychotics and extended-release naltrexone in the appropriate patient populations. Mechanism of action, dosing, need for oral medication overlap, and potential adverse effects will be explored. Participants will compare and contrast the different long-acting injectable antipsychotics and identify which agent(s) may be most appropriate based on patient and product characteristics. Participants will identify patients who may benefit from extended-release naltrexone and when initiation of extended-release naltrexone is appropriate. Finally, participants will be able to list advantages and disadvantages to the use of long-acting injectable antipsychotics and extended-release naltrexone to identify possible motivations for patient acceptance of these agents.

Amie Jo Digatono, PharmD, graduated from the University of Minnesota College of Pharmacy in 2011. She is a Board-Certified Psychiatric Pharmacist with experience treating patients with severe and persistent mental illness in a state behavioral health hospital and in a community hospital inpatient unit. Her experience also includes caring for patients with substance use disorders as well as dual diagnosis patients (those with co-occurring behavioral health and substance use disorders). She enjoys volunteering at the University of Minnesota College of Pharmacy, serving as a peer reviewer for the College of Psychiatric and Neurologic Pharmacists, and working as an election judge with the city of Minneapolis.

Julie Jackman is a doctor of pharmacy and Board Certified in Ambulatory Care. A 1999 graduate of the University of Pittsburgh, she has been practicing in mental health since 2008. Dr. Jackman has a holistic view when treating her patients, thanks to previous experience in community pharmacy, with additional training in diabetes and immunizations. Mental illness can impede a patient’s ability to care for themselves. Dr. Jackman strives to ensure her patients don’t fall through the cracks. Her unique practice was recognized in Pharmacy Today, a national pharmacy magazine, in 2009. Also in 2009, she was named Minnesota’s Distinguished Young Pharmacist. She was one of the original 512 pharmacists in the U.S. to earn the Board Certified Ambulatory Care Pharmacist (BC-ACP) designation in 2011. In 2014, she received the Individual Immunization Champion Award from the American Pharmacists Assocation (APhA) for her work in helping increase vaccination rates in the mental health population.


Register Now! APhA’s Delivering Medication Therapy Management Services

Friday, May 8 • 8 a.m.-5 p.m. • Facilitators: Jordan Wolf, PharmD, and Michelle Johnson, PharmD, BCACP • St. Paul

Join us for the next MTM certificate program in May. This program qualifies you to register as a provider with MN Medicaid and conduct and receive payment for Medication Therapy Management services. Seats are limited, so register today!

https://www.mpha.org/event/MTM-certificate-2020

APhA’s Delivering Medication Therapy Management Services Certificate training program (3rd Edition) presents a systematic approach for developing, implementing, delivering, and sustaining MTM services. It includes an overview of the marketplace for delivering MTM services, guidance for implementing MTM services in pharmacy practice, a review of the essential skills and knowledge needed for performing MTM successfully, and an organized process for identifying medication-related problems. The purpose of this certificate training program is to prepare pharmacists to improve medication use through the delivery of MTM services in a variety of practice settings.

Learn more and register now!


MSHP and MPhA Joint CE Event: Central Minnesota Resident Clinical Pearls 2020

Thursday, April 2, 5-7:30 p.m. • Courtyard by Marriott, St. Cloud

MPhA is pleased to partner with the Minnesota Society of Health-System Pharmacists to present Central Minnesota Resident Clinical Pearls. MPhA members may attend at no cost.

RSVP now!


Save the Dates: MPhA Events

May 21 • MPhA Virtual Town Hall: Long-Acting Injectables
June 10 • MPhA Leadership Summit and House of Delegates • Midland Hills Country Club, Roseville
June 16 • MPhA Town Hall: Long-Acting Injectables • Alexandria area
Sept. 8 • MPhA Town Hall: Long-Acting Injectables • Southwest Minnesota
Sept. 13 • MPhA Town Hall: Long-Acting Injectables • Mora area
Sept. 15 • MPhA Town Hall: Long-Acting Injectables • Duluth area

In this Issue

News from MPhA

COVID-19 Update

Mission Moments

COP Ranks Third among U.S. Pharmacy Schools

COP Faculty Receive Award from AACP

University of Minnesota Launches Clinical Trial to Prevent COVID-19

Pharmacy Students among Those Volunteering for MN Covidsitters

MPhA Needs Your Help

How Is COVID-19 Affecting Your Practice?

Minnesota News

Board of Pharmacy Provides FAQs on COVID-19

Legislators Approve $200 Million in Emergency Funding for COVID-19

Hospitals Plan for Stages of COVID-19 Patients

MHealth Fairview Offers Coronavirus Screening

Grocery Stores Alter Hours, Reserve Special Shopping Times for Those at Risk

National News

APhA Urges Insurers, PBMs to Remove Barriers on Prescription Refills

Pharmacy Groups Request Clarification from FDA on Compounding

NIH Clinical Trial of Investigational Vaccine for COVID-19 Begins

DEA National Prescription Drug Take Back Day: April 25


MPhA Events

Register Now! MPhA Virtual Town Hall: Long-Acting Injectables

Register Now! APhA’s Delivering Medication Therapy Management Services

MSHP and MPhA Joint CE Event: Central Minnesota Resident Clinical Pearls 2020

Save the Date: MPhA Events


Contact Us

Administrative Office
info@mpha.org

Executive Director
sarahd@mpha.org